Janus Henderson Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-34,456
Closed -$2.75M 874
2016
Q3
$2.75M Buy
34,456
+1,681
+5% +$136K 0.02% 425
2016
Q2
$2.56M Buy
32,775
+4,230
+15% +$302K 0.02% 430
2016
Q1
$1.57M Hold
28,545
0.01% 535
2015
Q4
$1.76M Hold
28,545
0.01% 499
2015
Q3
$1.8M Sell
28,545
-7,104
-20% -$507K 0.02% 490
2015
Q2
$2.6M Hold
35,649
0.02% 457
2015
Q1
$2.33M Hold
35,649
0.02% 492
2014
Q4
$2.32M Sell
35,649
-5,298
-13% -$341K 0.02% 488
2014
Q3
$2.46M Hold
40,947
0.02% 388
2014
Q2
$2.83M Hold
40,947
0.03% 362
2014
Q1
$2.68M Buy
40,947
+6,200
+18% +$404K 0.03% 368
2013
Q4
$2.15M Hold
34,747
0.02% 380
2013
Q3
$1.86M Sell
34,747
-2,821
-8% -$145K 0.02% 406
2013
Q2
$1.73M Buy
+37,568
New +$1.63M 0.02% 406

Other funds holding STJ

Janus Henderson Group's STJ Position: Q4 2016 in Review

Janus Henderson Group sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 34,456 shares — an estimated $2.75M sold.

Janus Henderson Group first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $2.83M in Q2 2014. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Janus Henderson Group reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Janus Henderson Group sold 34,456 St Jude Medical shares in Q4 2016, an estimated $2.75M.
  • Janus Henderson Group first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
  • Janus Henderson Group's St Jude Medical position peaked at $2.83M in Q2 2014.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Janus Henderson Group's 13F filing for Q4 2016, filed 30 Jan 2017.